Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Sampaio, Walkyria O ^a   Nascimento, Antônio A S ^a   Santos, Robson A S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Fluorescent microspheres; Regional blood flow

Indexed keywords

A 779; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN[1-7]; UNCLASSIFIED DRUG;

ADRENAL BLOOD FLOW; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRACHIAL ARTERY; BRAIN BLOOD FLOW; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; HEART INDEX; HEART OUTPUT; HEART RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; LUNG BLOOD FLOW; MALE; MESENTERY BLOOD FLOW; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN BLOOD FLOW; SPLEEN BLOOD FLOW; SYSTOLE; VASCULAR RESISTANCE; VASODILATATION;

EID: 0038024648     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01145.2002     Document Type: Article

References (61)

1. Almeida AP, Fabregas BC, Madureira MM, Santos RJS, Campagnole-Santos MJ, and Santos RAS. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Braz J Mol Biol Med 33: 709-713, 2000.
2. Benter IF, Diz DI, and Ferrario CM. Cardiovascular actions of angiotensin(1-7). Peptides 14: 679-684, 1993.
3. Beril T, Vries R, Saxena PR, and Danser AHJ. Bradykinin potentiation by angiotensin-(1-7) and ACE Inhibitors correlates with ACE C-and N-domain blockade. Hypertension 38: 95-99, 2001.
4. Braga AN, Silva Lemos M, Silva JR, Fontes WR, and Santos RAS. Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure. Am J Physiol Regul Integr Comp Physiol 282: R1663-R1671, 2002.
5. Brosnihan KB, Li P, and Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27: 523-528, 1996.
6. Clark MA, Diz DI, and Tallant EA. Angiotensin-(1-7) down-regulates the angiotensin II type I receptor in vascular smooth cells. Hypertension 37: 1141-1146, 2001.
7. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Back PH, Yagil Y, and Penninger JS. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828, 2002.
8. Deddish PA, Marcic B, Jackmann HL, Wang H, Skidgel RA, and Erdös EG. N-domain specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension 31: 912-917, 1998.
9. Dounohue M, Hsieh F, Baronas E, Gobout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breibart RE, and Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: e1-e9, 2000.
10. Fernandes L, Fortes ZB, Nigro D, Tostes RCA, Santos RAS, and Carvalho MHC. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studies in vivo. Hypertension 37: 703-709, 2001.
11. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, and Diz DI. Counterrregulatory action of angiotensin-(1-7). Hypertension 30: 535-541, 1997.
12. Ferrario CM. Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure? Circulation 105: 1523-1525, 2002.
13. Ferreira AJ, Santos RAS, and Almeida AP. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38: 665-668, 2001.
14. Ferreira AJ, Santos RA, and Almeida AP. Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts. Braz J Med Biol Res 35: 1083-1090, 2002.
15. Feterik K, Smith L, and Katusic ZS. Angiotensin-(1-7) causes endothelium-dependent relaxatation in canine middle cerebral artery. Brain Res 873: 75-82, 2000.
16. Freeman EJ, Chisolm GM, Ferrario CM, and Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28: 104-108, 1996.
17. Gervais M, Demolis SP, Domerg V, Lesage M, Richer C, and Giudicelli JF. Systemic and regional hemodynamics assessment in rats with fluorescent microspheres. J Cardiovasc Pharmacol 33: 425-432, 1999.
18. 3H]norepinephrine from rat atria. Hypertension 24: 457-460, 1994.
19. Gironacci MM, Coba MP, and Pena C. Angiotensin-(1-7) binds at the type I angiotensin II receptors in rat renal cortex. Regul Pept 84: 51-54, 1998.
20. Glenny RW, Bernard S, and Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol 74: 2585-2597, 1993.
21. Handa RK. Binding and signaling of angiotensin-(1-7) in bovine kidney epithelial cells involves the AT (4) receptor. Peptides 21: 729-736, 2000.
22. Heitsch H, Brovkovych S, Malinsk T, and Wiemer G. Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 37: 72-76, 2001.
23. 2 release. Hypertension 25: 1238-1244, 1995.
24. Iyer SN, Yamada K, Diz DI, Ferrario CM, and Chappel MC. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the reninangiotensin system. J Cardiovasc Pharmacol 36: 109-117, 2000.
25. Kucharewicz I, Pawlak R, Matys T, Pawlak D, and Buczko W. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7). Hypertension 40: 774-779, 2002.
26. Kumagai H, Khosla MC, Ferrario C, and Fouad-Tarazi FM. Biological activity of angiotensin-(1-7) heptaptide in the hamster heart. Hypertension 29: 394-400, 1990.
27. Lemos VS, Cortes SF, Silva DM, Campgnole-Santos MJ, and Santos RA. Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylefrine-induced contraction in the aorta of m-Ren transgenic rats. Br J Pharmacol 135: 1743-1748, 2002.
28. Li P, Chappell MC, Ferrario CM, and Brosnihan KB. Angiotensin-(1-7) augments bradikinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29: 394-400, 1997.
29. Lima CV, Paula RD, Resende FL, Khosla MC, and Santos RAS. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 30: 542-548, 1997.
30. Loot AE, Roks AJ, Henning Rh Tio RA, Suurmeijer AJ, Boosmasma F, and van Gilst WH. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105: 1548-1550, 2002.
31. Machado RD, Ferreira MA, Belo AV, Santos RA, and Andrade SP. Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature. Regul Pept 107: 105-113, 2002.
32. Machado RP. Estudo Autorradiográfico da Ligação da 1251-Ang-(1-7) em Rim de Rato. Belo Horizonte, MG, Brazil: Universidade Federal de Minas Gerais, 1999, Thesis.
33. Mahon JM, Carr RD, Nicol AK, and Henderson IW. Angiotensin-(1-7) is an antagonist at the type I angiotensin II receptor. J Hypertens 12: 1377-1381, 1994.
34. Marcic B, Deddish PA, Jackman HL, and Erdös EG. Enhancement of bradykinin and resensitization of its B2 receptor. Hypertension 33: 835-843, 1999.
35. Mendes EP, Vieira MAR, and Santos RAS. Interaction between angiotensin-(1-7) and kinins in renal hemodynamic (Abstract). Hypertension 37: 1026, 2001.
36. Meng W and Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke 24: 2041-2045, 1993.
37. Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, and Ganten D. Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 357: 27-32, 1995.
38. Moritz KM, Campbell DJ, and Wintour EM. Angiotensin-(1-7) in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 280: R404-R409, 2001.
39. Muthalif MM, Benter IF, Uddin MR, Haper JL, and Malik KU. Signal transduction mechanism involved in angiotensin- (1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth cells. J Pharmacol Exp Ther 284: 388-398, 1998.
40. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, and Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension 37: 77-83, 2001.
41. Oliveira MA, Fortes ZB, Santos RAS, Khosla MC, and De Carvalho MHC. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Peptides 20: 1195-1201, 1999.
42. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, and Kadowitz PJ. Differential responses to Ang-(1-7) in the feline mesenteric and hindquarter vascular beds. Eur J Pharmacol 234: 35-42, 1993.
43. Paula RD, Lima CV, Khosla MC, and Santos RAS. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 26: 1154-1156, 1995.
44. Pörsti I, Bara AT, Busse R, and Hecker M. Release of oxide nitric by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 111: 652-654, 1994.
45. Ren Y, Garvin JL, and Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 39: 799-802, 2002.
46. Roks AMJ, Van Geel PP, Pinto YM, Buikema H, Henning RH, De Zeeuw D, and Van Gilst WH. Angiotensin-(1-7) is a modulator of the human renin angiotensin system. Hypertension 34: 296-301, 1999.
47. Santos RAS, Brosnihan KB, Jacobsen NDW, Dicorleto PE, and Ferrario CM. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 19, Suppl II: II56-II61, 1992.
48. Santos RAS, Campgnole-Santos MJ, and Andrade SP. Angiotensin-(1-7): an update. Regul Pept 91: 45-62, 2000.
49. Santos RAS, Campagnole-Santos MJ, Baracho NCV, Fontes MA, Silva LC, Neves LA, Oliveira DR, Caligiorne SM, Rodrigues ARV, Gropen C Jr, Carvalho WS, Silva AC, and Khosla MC. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull 35: 293-298, 1994.
50. Santos RAS, Simões e Silva AC, Marie C, Speth R, Machado RP, Pinheiro SV, Lopes MT, Mendes EP, Bader M, Schultheiss HP, Campagnole-Santos MJ, and Walther T. Evidence that angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas (Abstract). Hypertension 40: 387, 2002.
51. Santos RAS, Passaglio KT, Pesquero JB, Bader M, Simões e and Silva AC. Interactions between kinins and angiotensin-(1-7) in kidney and blood vessels. Hypertension 38: 660-664, 2001.
52. Santos RAS, Simões e Silva AC, Maric C, Speth R, Machado RP, Pinheiro SV, Lopes MT, Mendes EP, Bader M, Schultheiss HP, Campagnole-Santos MJ, and Walther T. Evidence that angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor mass. 56th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in Association with the Council on the Kidney in Cardiovascular Disease, September 25-28, 2002.
53. Sasaki S, Higashi Y, Nakagawa K, Matsuura H, Kajiyama G, and Oshima T. Angiotensin-(1-7) induces endothelium-independent vasodilation in normotensive control subjects and essential hypertensive patients. Hypertension 38: 90-94, 2001.
54. Simões e Silva AC, Baracho NC, Passaglio KT, and Santos RA. Renal actions of angiotensin-(1-7). Braz J Med Biol Res 30: 503-513, 1997.
55. Tallant EA, Lu X, Weiss RB, Chappel MC, and Ferrario C. Bovine endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 29: 388-393, 1997.
56. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, and Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000.
57. Tran Y and Forster C. Angiotensin-(1-7) and the rat aorta: modulation by endothelium. J Cardiovasc Pharmacol 30: 676-682, 1997.
58. Ueda S, Masumori-Maemoto S, Ashino K, Nagahara T, Gotoh E, Umemura S, and Ishii M. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension 35: 998-1001, 2000.
59. Van Oosterhout MFM, Willigers MM, Renaman RS, and Prizen FW. Fluorescent microspheres to measure organ perfusion: validation of a simplified sample processing technique. Am J Physiol Heart Circ Physiol 269: H725-H733, 1995.
60. Widdop RE, Sampey DB, and Jarrott B. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats. Hypertension 34: 964-968, 1999.
61. Zhu Z, Zhong J, Zhu S, Liu D, Vander Giet M, and Tepel M. Angiotensin-(1-7) inhibits angiotensin-II-induced signal transduction. J Cardiovasc Pharmacol 40: 693-700, 2002.